Literature DB >> 2952630

Distribution of light chains and ATPase activity of myosin in the atrioventricular conducting tissue of bovine heart.

Y Tamura, S Orino, Y Saijyo, T Nishimoto, N Nagase, H Mori.   

Abstract

The relations of the light chains of myosins of the atria, ventricles, and atrioventricular conducting tissue (specialized myocardial tissue) and the distribution of the light chains of myosin in different regions of the atrioventricular conducting tissue in bovine heart were examined. Two-dimensional gel electrophoresis showed that the atrial and ventricular myosins each had two light chains (LC1 and LC2). Ventricular LC1 differed from atrial LC1, but ventricular LC2 corresponded to atrial LC2. The specialized myocardial tissue myosin had three light chains (named here SL1, SL2, and SL3). SL1 comigrated with ventricular LC1, SL2 with atrial LC1, and SL3 with ventricular LC2 and atrial LC2. The compositions of the three light chains of myosins in various regions of the atrioventricular conducting tissue were determined by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis. The percentage proportion of SL1 decreased in the order--atrioventricular node (AVN), right and left bundle branches (RLBB), His bundle (HIS), false tendon (FT) myosin; while the percentage proportion of SL2 decreased in the order--FT and HIS, RLBB, AVN myosin. The percentages of SL3 in these four regions were similar. The Ca2+-activated ATPase activity of myosin was highest in the AVN and lowest in the FT. The activities in the HIS and RLBB were intermediate between those in the AVN and FT. Thus, the composition of the light chains and the Ca2+-activated ATPase activity were different in various regions of the atrioventricular conducting tissue.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2952630     DOI: 10.1007/bf02059969

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   2.037


  41 in total

1.  Differences in atrial and ventricular myosin light chain LC1.

Authors:  J Wikman-Coffelt; S Srivastava
Journal:  FEBS Lett       Date:  1979-10-01       Impact factor: 4.124

2.  Immunohistochemical evidence for myosin polymorphism in the chicken heart.

Authors:  S Sartore; S Pierobon-Bormioli; S Schiaffino
Journal:  Nature       Date:  1978-07-06       Impact factor: 49.962

3.  Comparative analysis of chicken atrial and ventricular myosins.

Authors:  L D Libera; S Sartore; S Schiaffino
Journal:  Biochim Biophys Acta       Date:  1979-12-14

4.  Chromatography of myosin on diethylaminoethyl-Sephadex A-50.

Authors:  E G Richards; C S Chung; D B Menzel; H S Olcott
Journal:  Biochemistry       Date:  1967-02       Impact factor: 3.162

5.  Thyroxine-induced redistribution of isoenzymes of rabbit ventricular myosin.

Authors:  A F Martin; E D Pagani; R J Solaro
Journal:  Circ Res       Date:  1982-01       Impact factor: 17.367

6.  Foetal myosin light chain in human ventricle.

Authors:  P Cummins; K M Price; W A Littler
Journal:  J Muscle Res Cell Motil       Date:  1980-09       Impact factor: 2.698

7.  Fiber types and myosin types in human atrial and ventricular myocardium. An anatomical description.

Authors:  P Bouvagnet; J Leger; F Pons; C Dechesne; J J Leger
Journal:  Circ Res       Date:  1984-12       Impact factor: 17.367

8.  Relationship between myosin isoenzyme composition, hemodynamics, and myocardial structure in various forms of human cardiac hypertrophy.

Authors:  H O Hirzel; C R Tuchschmid; J Schneider; H P Krayenbuehl; M C Schaub
Journal:  Circ Res       Date:  1985-11       Impact factor: 17.367

9.  Transitions in human atrial and ventricular myosin light-chain isoenzymes in response to cardiac-pressure-overload-induced hypertrophy.

Authors:  P Cummins
Journal:  Biochem J       Date:  1982-07-01       Impact factor: 3.857

10.  Myosin types and fiber types in cardiac muscle. I. Ventricular myocardium.

Authors:  S Sartore; L Gorza; S Pierobon Bormioli; L Dalla Libera; S Schiaffino
Journal:  J Cell Biol       Date:  1981-01       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.